3,511 results found

On September 30, 2020, the Federal Court dismissed an application by Catalyst Pharmaceuticals Inc and KYE Pharmaceuticals Inc (collectively, the applicants) for an interlocutory injunction to stay the decision of the Minister of Health ...

The Federal Court had previously allowed a concurrent trial on common invalidity issues in actions under the Patented Medicines (Notice of Compliance) Regulations (PMNOC Regulations)...

The Federal Court of Appeal found that the application judge made no reviewable error in finding that the TPD's decision was not improperly motivated, and dismissed the appeal.

On April 1, 2019, Gabriella's Kitchen Inc. ("GABY") (CSE: GABY) announced the completion of its previously announced acquisition of all of the issued and outstanding shares ...

On November 27, 2017, Health Canada announced the release of Guidance Document: Use of a Foreign-sourced Reference Product as a Canadian Reference Product.

The Government of Canada announced in its 2014 federal budget that it intends to modernize the compositional standards for beer under the Food and Drug Regulations.

Health Canada announced July 31 that it would be changing the labelling requirements for certain homeopathic remedies, and would no longer be permitting certain previously allowed claims.

As previously reported, Health Canada conducted stakeholder consultations and analysis of issues related to the naming of biologic drugs, including biosimilars.

On February 11, 2019, Health Canada released its Cannabis Voluntary Recall Guide, a copy of which can be accessed here.

Health Canada intends to pre-publish the proposed regulatory amendments in 2019.

On November 20, 2024, Health Canada posted Drug shortages in Canada: Fiscal year 2023 to 2024 in review. The review includes an overview of drug shortages...

On February 7, 2018, Health Canada published an update to the guidance document Classification of Products at the (Medical) Device-Drug Interface.

On April 24, 2026, Health Canada announced that sports electrolyte products will transition from the natural health product (NHP) framework to the supplemented food regulatory framework...

The Generic Submissions Under Review (GSUR) list (previously reported) is a list of Abbreviated New Drug Submissions (generic submissions) ...

Health Canada announced it will move forward with Phase III of its prescription drug product transparency initiatives.

On June 10, 2020, Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) ("Innocan") announced the closing of its marketed short form prospectus offering of units for gross proceeds of $5,116,309.74.

Murray Coleman comments in the Globe and Mail's look at the vertical farming industry, where proponents say these farms can supply greens all year to Canadians...